Last updated: 11/07/2018 14:04:20
A double-blind, multicentre, parallel group study of paroxetine and amitriptyline in the treatment of patients with depression associated with breast cancer
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A double-blind, multicentre, parallel group study of paroxetine and amitriptyline in the treatment of patients with depression associated with breast cancer
Trial description: A double-blind, multicentre, parallel group study of paroxetine and amitriptyline in the treatment of patients with depression associated with breast cancer
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
A double-blind comparative study of the effectiveness and tolerance of paroxetine and amitriptyline in treatment of breast cancer patients with clinically assessed depression: eine doppelblinde vergleichsstudie zur wirksamkeit und vertraglichkeit von paroxetin und amitriptylin bei der behandlung von brustkrebs-patientinnen mit klinisch nachgewiesener depression. Moslinger-Gehmayr, R., Zaninelli, R., Contu, A., Oberhoff, C., Gutschow, K., Schindler, A. E., and Staab, H. J. Zentralbl Gynakol 2000; 122(4):195-202
Depression in breast cancer patients - comparison of paroxetine and amitriptyline. A. Contu 10th Annual Congress of the European College of Neuropsychopharmacology (ECNP) 9/13/1997 Vienna; Austria
Depression in patients with breast cancer: a comparative study. Moslinger-Gehmayr, Regina 11th World Congress of Psychiatry (World Psychiatric Association) 8/6/1999 Hamburg; Germany
Pezzella et al. Treatment of depression in patients with breast cancer: a comparison between paroxetine vs amitriptyline. Breast Cancer Research and Treatment 2001; 70 (1): 1-10
Medical condition
Depressive Disorder
Product
paroxetine
Collaborators
Not applicable
Study date(s)
October 1994 to December 1996
Type
Not applicable
Phase
4
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
1996-31-12
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website